SPPI — Spectrum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $211.40m
- $184.11m
- $10.11m
Spectrum Pharma rises on upbeat prelim Q4 revenue
Brief: Spectrum Pharmaceuticals Announces Management Changes
Brief: Spectrum Pharmaceuticals’ROLVEDON (Eflapegrastim-Xnst) Injection Added To NCCN Supportive Care Guidelines In Oncology For Hematopoietic Growth Factors
U.S. STOCKS ON THE MOVE-Cidara, Agora, Manchester United
U.S. STOCKS ON THE MOVE-Apple, Activision Blizzard, Manchester United
U.S. STOCKS ON THE MOVE-Energy firms, Tesla, Activision Blizzard
U.S. STOCKS ON THE MOVE-Spectrum Pharma, Activision Blizzard
Spectrum Pharma drops as FDA declines to approve lung cancer drug
U.S. FDA declines to approve Spectrum Pharmaceuticals' lung cancer drug (updated)
U.S. FDA declines to approve Spectrum Pharmaceuticals' lung cancer drug
Brief: Spectrum Pharmaceuticals Receives Complete Response Letter From U.S. Food And Drug Administration For Poziotinib
Spectrum Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Spectrum Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.12
Spectrum Pharmaceuticals Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Spectrum Pharmaceuticals Notified By Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE- Boston Beer, Snap, Exxon, Oracle
U.S. STOCKS ON THE MOVE- Biohaven, Boston Beer, Exxon
U.S. STOCKS ON THE MOVE-Schlumberger, Spectrum Pharma
Spectrum Pharma rises on launch of neutropenia drug